Melanoma cells secrete follistatin, an antagonist of activin-mediated growth inhibition

Oncogene

Volumn 23, Issue 31, 2004, Pages 5330-5339

  Stove, Christophe ^a,c   Vanrobaeys, Frank ^b   Devreese, Bart ^b   Van Beeumen, Jozef ^b   Mareel, Marc ^a   Bracke, Marc ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Activin; Apoptosis; Follistatin; Growth; Melanoma; Smad

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR; FOLLISTATIN; HEPARIN; LUCIFERASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; LIGAND; LIPOCORTIN 5;

ARTICLE; CANCER CELL CULTURE; GROWTH INHIBITION; HUMAN; MELANOCYTE; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEOMICS; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; APOPTOSIS; BIOSYNTHESIS; CELL DIVISION; DOSE RESPONSE; GENETICS; IMMUNOBLOTTING; MASS SPECTROMETRY; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE; REPORTER GENE; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; TUMOR CELL LINE; WESTERN BLOTTING;

ACTIVIN RECEPTORS; ACTIVINS; AMINO ACID SEQUENCE; ANNEXIN A5; APOPTOSIS; BLOTTING, WESTERN; CELL DIVISION; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLISTATIN; GENES, REPORTER; HUMANS; IMMUNOBLOTTING; LIGANDS; LUCIFERASES; MASS SPECTROMETRY; MELANOCYTES; MELANOMA; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 3142660426     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207699     Document Type: Article

References (56)

1. Alanko T and Saksela O. (2000). J. Invest. Dermatol., 115, 286-291.
2. Ball EMA and Risbridger GP. (2001). Dev. Biol., 238, 1-12.
3. Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J and Bartek J. (1996). Cancer Res., 56, 5475-5483.
4. Beer H-D, Gassmann MG, Munz B, Steiling H, Engelhardt F, Bleuel K and Werner S. (2000). J. Investig. Dermatol. Symp. Proc., 5, 34-39.
5. Berking C, Takemoto R, Schaider H, Showe L, Satyamoorthy K, Robbins P and Herlyn M. (2001). Cancer Res., 61, 8306-8316.
6. Blume-Jensen P and Hunter T. (2001). Nature, 411, 355-365.
7. Chen Y-G, Lui HM, Lin S-L, Lee JM and Ying SY. (2002). Exp. Biol. Med., 227, 75-87.
8. Cho SH, Yao Z, Wang S-W, Alban RF, Barbers RG, French SW and Oh CK. (2003). J. Immunol., 170, 4045-4052.
9. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JWC, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR and Futreal PA. (2002). Nature, 417, 949-954.
10. Delbaere A, Sidis Y and Schneyer AL. (1999). Endocrinology, 140, 2463-2470.
11. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S and Gauthier J-M. (1998). EMBO J., 17, 3091-3100.
12. Devreese B, Janssert KPC, Vanrobaeys F, Van Herp F, Martens GJM and Van Beeumen J. (2002). J. Chromatogr. A., 976, 113-121.
13. de Winter JP, ten Dijke P, de Vries CJM, van Achterberg TAE, Sugino H, de Waele P, Huylebroeck D, Verschueren K and van den Eijnden-van Raaij AJM. (1996). Mol. Cell. Endocrinol., 116, 105-114.
14. Esch FS, Shimasaki S, Mercado M, Cooksey K, Ling N, Ying S, Ueno N and Guillemin R. (1987). Mol. Endocrinol., 1, 849-855.
15. Gray PC, Harrison CA and Vale W. (2003). Proc. Natl. Acad. Sci. USA, 100, 5193-5198.
16. Gullick WJ. (2001). Breast Cancer Res., 3, 390-394.
17. Gumienny TL and Padgett RW. (2002). Trends Endocrinol. Metab., 13, 295-299.
18. Hager JW. (2002). Rapid Commun. Mass Spectrom., 16, 512-526.
19. Hashimoto O, Nakamura T, Shoji H, Shimasaki S, Hayashi Y and Sugino H. (1997). J. Biol. Chem., 272, 13835-13842.
20. Hempen PM, Zhang L, Bansal RK, Iacobuzio-Donahue CA, Murphy KM, Maitra A, Vogelstein B, Whitehead RH, Markowitz SD, Willson JKV, Yeo CJ, Hruban RH and Kern SE. (2003). Cancer Res., 63, 994-999.
21. Innis CA and Hyvönen M. (2003). J. Biol. Chem., 278, 39969-39977.
22. Inouye S, Guo Y, DePaolo L, Shimonaka M, Ling N and Shimasaki S. (1991). Endocrinology, 129, 815-822.
23. Knight PG. (1996). Front. Neuroendocrinol., 17, 476-509.
24. Lázár-Molnár E, Hegyesi H, Tóth S and Falus A. (2000). Cytokine, 12, 547-554.
25. Ling N, Ying S-Y, Ueno N, Shimasaki S, Esch F, Hotta M and Guillemin R. (1986). Nature, 321, 779-782.
26. Liu QY, Niranjan B, Gomes P, Gomm JJ, Davies D, Coombes RC and Buluwela L. (1996). Cancer Res., 56, 1155-1163.
27. Luisi S, Florio P, Reis FM and Petraglia F. (2001). Eur. J. Endocrinol., 145, 225-236.
28. Massagué J and Chen Y-G. (2000). Genes Dev., 14, 627-644.
29. Meier F, Satyamoorthy K, Nesbit M, Hsu M-Y, Schittek B, Garbe C and Herlyn M. (1998). Front. Biosci., 3, D1005-D1010.
30. Michel U and Farnworth P. (1992). Endocrinology, 130, 3684-3693.
31. Munz B, Smola H, Engelhardt F, Bleuel K, Brauchte M, Lein I, Evans LW, Huylebroeck D, Balling R and Werner S, (1999). EMBO J., 18, 5205-5215.
32. Nakamura T, Takio K, Eto Y, Shibai H, Titani K and Sugino H. (1990), Science, 247, 836-838.
33. Risbridger GP, Schmitt JF and Robertson DM. (2001). Endocr. Rev., 22, 836-858.
34. Robertson DM, Klein R, de Vos FL, McLachlan RI, Wettenhall REH, Hearn MTW, Burger HG and de Kretser DM. (1987). Biochem. Biophys. Res. Commun., 149, 744-749.
35. Rodeck U, Bossler A, Graeven U, Fox FE, Nowell PC, Knabbe C and Kari C. (1994). Cancer Res., 54, 575-581.
36. Rodeck U, Nishiyama T and Mauviel A. (1999). Cancer Res., 59, 547-550.
37. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E and Polakis P. (1997). Science, 275, 1790-1792.
38. Sandra K, Devreese B, Stals I, Claeyssens M and Van Beeumen J. (2003). J. Am. Soc. Mass Spectrom., 15, 413-423.
39. Schneyer AL, Hall HA, Lambert-Messerlian G, Wang QF, Sluss P and Crowley Jr WF. (1996). Endocrinology, 137, 240-247.
40. Schneyer AL, Rzucidlo DA, Sluss PM and Crowley Jr WF. (1994). Endocrinology, 135, 667-674.
41. Shellman YG, Chapman JT, Fujita M, Norris DA and Maxwell IH. (2000). J. Invest. Dermatol., 114, 1200-1204.
42. Shi Y and Massagué J. (2003). Cell, 113, 685-700.
43. Shimasaki S, Koga M, Esch F, Cooksey K, Mercado M, Koba A, Ueno N, Ying S-Y, Ling N and Guillemin R. (1988). Proc. Natl. Acad. Sci. USA, 85, 4218-4222.
44. Sidis Y, Schneyer AL, Sluss PM, Johnson LN and Keutmann HT. (2001). J. Biol. Chem., 276, 17718-17726.
45. Sidis Y, Tortoriello DV, Holmes WE, Pan Y, Keutmann HT and Schneyer AL. (2002). Endocrinology, 143, 1613-1624.
46. Stove C, Stove V, Derycke L, Van Marck V, Mareel M and Bracke M. (2003a). J. Invest. Dermatol., 121, 802-812.
47. Stove V, Naessens E, Stove C, Swigut T, Plum J and Verhasselt B. (2003b). Blood, 102, 2925-2932.
48. Tano M, Minegishi T, Nakamura K, Nakamura M, Karino S, Miyamoto K and Ibuki Y. (1995). Mol. Cell. Endocrinol., 109, 167-174.
49. Tuveson DA, Weber BL and Herlyn M. (2003). Cancer Cell, 4, 95-98.
50. Ueno N, Ling N, Ying S-Y, Esch F, Shimasaki S and Guillemin R. (1987). Proc. Natl. Acad. Sci. USA, 84, 8282-8286.
51. Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, Karr D and Spiess J. (1986). Nature, 321, 776-779.
52. Wang Q, Keutmann HT, Schneyer AL and Sluss PM. (2000). Endocrinology, 141, 3183-3193.
53. Wankell M, Kaesler S, Zhang Y-Q, Florence C, Werner S and Duan R. (2001a). J. Endocrinol., 171, 385-395.
54. Wankell M, Munz B, Hübner G, Hans W, Wolf E, Goppelt A and Werner S. (2001b). EMBO J., 20, 5361-5372.
55. Welt C, Sidis Y, Keutmann H and Schneyer A. (2002). Exp. Biol. Med., 227, 724-752.
56. Willert J, Epping M, Pollack JR, Brown PO and Nusse R. (2002). BMC Dev. Biol., 2, 8.